Overview

Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the impact of SH T00658ID (EV/DNG tablet) on hemostatic parameters in comparison to a reference oral contraceptive (OC) (SH D01155E) in a crossover design.

Phase:

Phase 2

Details

Lead Sponsor:

Bayer

Treatments:

Contraceptive Agents
Ethinyl Estradiol
Hemostatics
Levonorgestrel